On subset analysis of endocrinopathies, 7/39 patients had stunted growth with 3 patients displaying an advanced bone age, 2 with a delayed bone age, 1 requiring growth hormone for significantly impeded height, and 1 for ongoing height surveillance with no active intervention. This evidence concerns the gene GH1 and endocrine system disorder.